Objective: The purpose of this study was to determine the compliance rate with a maternal riskfactor-based guideline for the prevention of neonatal group B streptococcal (GBS) 
ceive intrapartum antibiotic prophylaxis, all were between 34 and 36 weeks of gestation.
We found prolonged rupture of membranes in 5% (37 of 805)of women. For these, the compliance rate was 73% (27 or 37). Of the non-compliant cases, 6 of 10 (60%) had a duration of rupture of membranes between 18 and 19 h and 9 of 10 (90%) had a duration of rupture of <24 h. There were 3 patients with a previous child affected by GBS; all of these received intrapartum antibiotics. Of 5 women with a positive urinary or genital GBS culture, 4 received intrapartum prophylaxis in the absence of other specified risk factors.
Two neonates during the study period were treated after birth for blood culture positive GBS sepsis. Neither mother received intrapartum antibiotic therapy nor had any risk factor. One mother underwent induction at 40 weeks of gestation for a low amniotic fluid index. She received two prostaglandin suppositories and oxytocin and delivered within 14 h after placement of the first suppository. Membranes were ruptured 3 h before delivery, and the mother was afebrile during her labor. The neonate was admitted to the neonatal intensive care unit (NICU) for hypoglycemia and blood cultures were subsequently positive for GBS. The second patient labored spontaneously at 40 weeks of gestation. Membranes were ruptured for 8 h prior to delivery and the mother was afebrile during her labor. After a forceps delivery, the baby was taken to the NICU for presumptive meconium aspiration. Both babies were discharged within 14 days of delivery, received home intravenous antibiotic therapy, and recovered without sequelae.
DISCUSSION
We found that compliance with this risk-factorbased guideline for the prevention of neonatal GBS 
